@article{99e29b2b2b2b49daa06a5cf3c11e0025,
title = "Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region",
abstract = "Recent studies with avian embryos and murine embryonic stem cells have suggested that hematopoietic cells are derived from hemangioblasts, the common precursors of hematopoietic and endothelial cells. We molecularly cloned podocalyxin-like protein 1 (PCLP1) as a novel surface marker for endothelial-like cells in the aorta-gonad-mesonephros (AGM) region of mouse embryos, where long-term repopulating hematopoietic stem cells (LTR-HSCs) are known to arise. PCLPI+ CD45- cells in the AGM region incorporated acetylated low-density lipoprotein and produced both hematopoietic and endothelial cells when cocultured with OP9 stromal cells. Moreover, multiple lineages of hematopoietic cells were generated in vivo when PCLP1+CD45- cells were injected into neonatal liver of busulfan-treated mice. Thus, PCLP1 can be used to separate hemangioblasts that give rise to LTR-HSCs.",
author = "Takahiko Hara and Nakano, {Yoh ko} and Minoru Tanaka and Kazuhiro Tamura and Takashi Sekiguchi and Minehata, {Ken ichi} and Copeland, {Neal G.} and Jenkins, {Nancy A.} and Masaru Okabe and Hiroshi Kogo and Mukouyama, {Yoh suke} and Atsushi Miyajima",
note = "Funding Information: We are grateful to S. Nishikawa (Kyoto University) for valuable suggestions and for providing us with anti-VECadherin antibody and OP9 cell line. We thank M. Yoder (Indiana University) for kind instructions on neonatal liver injection and Debra J. Gilbert for excellent technical assistance during chromosome mapping. M. T. and Y. M. are recipients of Research Fellowships of the Japan Society for the Promotion of Science for young scientists. This work was partly supported by Grants-in-Aid for Scientific Research from Monbusho, grants from CREST, The Takeda Foundation, Riken, and The Organization for Pharmaceutical Safety and Research. This research was also supported, in part, by the National Cancer Institute, Department of Health and Human Services, under contract with Advanced Bioscience Laboratories. ",
year = "1999",
month = nov,
doi = "10.1016/S1074-7613(00)80132-6",
language = "English (US)",
volume = "11",
pages = "567--578",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "5",
}